Free Radicals
Free Radicals
✓

How GLP-1s are paving the way for the new era of biotech - Elliot Hershberg, Investor & Blogger

01:05:51
Podcasts
RSS
Link

ОБ ЭТОМ ЭПИЗОДЕ

Elliot Hershberg is a partner at Amplify Partners and author of the popular blog Century of Biology. In this episode, we talk about GLP-1s as a breakthrough moment for biotech, why drug development is starting to behave like software, and how falling discovery costs could finally free biotech startups from selling themselves to pharma.

We also talk about Elliot’s "massive markets, medium prices" thesis, the rise of consumer and "n-of-one" medicine, and Sid Sijbrandij going founder mode on his cancer by measuring himself, using AI to build a pipeline of personalized therapies, and is now disease-free. 

Thank you to SynBioBeta for hosting us at their conference, where we recorded this episode, and several others we’ll be releasing soon!

Check out Elliot's blog at centuryofbio.com

Ciencias de la vida
Естественные науки
английский
США
ИспользуйтеAPI, чтобы загрузить этот эпизод вJSON.

В ЭТОМ ЭПИЗОДЕ

Изменить эти теги

РАСШИФРОВКА 🔗

Are you the producer of this podcast? Add a podcast transcript
Need Audio-to-Text? Transcribe with Listen411 in Just 60 Seconds

ПОИСК ПРОШЛЫХ ЭПИЗОДОВ

Искать прошлые эпизоды Free Radicals.
Вставьте эту панель поиска на свой сайт

ДРУГИЕ ЭПИЗОДЫ В ЭТОМ ПОДКАсте

The one-man biotech is only 10 years away - a16z-backed founder Kexin Huang

The one-man biotech is only 10 years away - a16z-backed founder Kexin Huang

Today’s guest is Kexin Huang. Kexin recently raised $13.5M from Andreessen Horowitz and Menlo Ventures in partnership with Anthropic, to build Phylo - a research lab studying agentic biology. Phylo’s first product is Biomni, the world’s first open source IBE or Integrated Biology Environment for co…
01:10:41
ПОДЕЛИТЬСЯ
СОХРАНИТЬ
Aging kills EVERYONE, but only because we're not trying hard enough - Longevity Activist Nathan Cheng

Aging kills EVERYONE, but only because we're not trying hard enough - Longevity Activist Nathan Cheng

Nathan Cheng is an activist who has dedicated his life and career to defeating aging and death. After going through an existential crisis and dropping out of a Physics PhD, Nathan discovered the longevity movement and became one of the most prolific activists in the space. He is a founder of Longev…
01:26:28
ПОДЕЛИТЬСЯ
СОХРАНИТЬ
There are no longevity drugs today, but there will be soon - Dr. James Peyer, Cambrian Founder

There are no longevity drugs today, but there will be soon - Dr. James Peyer, Cambrian Founder

Dr. James Peyer is founder and CEO of Cambrian Bio. James has spent two decades working to bring the first longevity drug to market. In this time, he’s brought over $500M into the field as a whole, and now has multiple drugs in clinical trials that could plausibly prove to be… the first true longev…
01:21:43
ПОДЕЛИТЬСЯ
СОХРАНИТЬ
These 30-something Harvard Professors are making biology programmable - AbuGoot Lab

These 30-something Harvard Professors are making biology programmable - AbuGoot Lab

Two young Harvard professors are coming for the supplements industry. Dr. Jonathan Gootenberg and Dr. Omar Abudayyeh run a joint lab at Harvard Medical School, have co-founded 4 biotechs, and raised over $300M to develop genetic medicines and diagnostics. But what surprised me most: they think like…
01:15:29
ПОДЕЛИТЬСЯ
СОХРАНИТЬ
Отказ от ответственности: Подкаст и иллюстрации, встроенные в эту страницу, взяты из Daniel Shur and Eric Dai, который является собственностью его владельца и не связан или не одобрен Listen Notes, Inc.
PROMOTED
We’re selling some of our podcast-related domain names, including breaker.fm, Podcast.mov, and Listen.Host. Place your bid on eBay.
We’re selling some of our podcast-related domain names, including breaker.fm, Podcast.mov, and Listen.Host. Place your bid on eBay.
Bid on eBay

РЕКОМЕНДАЦИИ
Используйте API, чтобы скачать этот эпизод